MONTELUKAST SODIUM | A078605 | TEVA PHARMACEUTICALS USA
Total Spending
$190.7M
Total Claims
11,936,320
Beneficiaries
3,063,882
Avg Cost/Unit
$0.25
Spending Trend
Source: CMS Medicare Part D Spending by Drug (2023). Shows gross drug cost under Part D.
23 active API suppliers hold Drug Master Files for this ingredient.
Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.
| Date | Submission | Document |
|---|---|---|
| Aug 6, 2012 | ORIG -1 | View Letter (PDF) |
Source: Drugs@FDA application documents.
No patent or exclusivity listings for this strength.